BP
BIIB icon

BBR Partners’s Biogen BIIB Stock Holding History

BBR Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,298
Closed -$265K – 186
2022
Q2 		$265K Hold
1,298
– – 0.03% 175
2022
Q1 		$273K Buy
1,298
+11
+0.9% +$2.39K 0.03% 192
2021
Q4 		$309K Hold
1,287
– – 0.04% 157
2021
Q3 		$364K Hold
1,287
– – 0.03% 156
2021
Q2 		$446K Sell
1,287
-5
-0.4% -$1.51K 0.04% 123
2021
Q1 		$361K Buy
1,292
+2
+0.2% +$539 0.03% 151
2020
Q4 		$316K Buy
1,290
+3
+0.2% +$774 0.03% 142
2020
Q3 		$365K Buy
+1,287
New +$359K 0.03% 134

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BBR Partners's BIIB Position: Q3 2022 in Review

BBR Partners sold out of Biogen (BIIB) in Q3 2022, closing a stake of 1,298 shares — an estimated $265K sold.

BBR Partners first reported a position in BIIB in Q3 2020 and held it in 8 quarters. The position peaked at $446K in Q2 2021. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • BBR Partners reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • BBR Partners sold 1,298 Biogen shares in Q3 2022, an estimated $265K.
  • BBR Partners first reported a position in Biogen in Q3 2020 and held it in 8 quarters.
  • BBR Partners's Biogen position peaked at $446K in Q2 2021.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on BBR Partners's 13F filing for Q3 2022, filed 10 Nov 2022.